• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 10, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Dr. Joe Northup Becomes 40th President of Metabolic Surgery Society

Bioengineer by Bioengineer
July 10, 2026
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Joe Northup, MD, a distinguished surgeon and researcher at Vanderbilt University Medical Center, has been elected the 40th president of the American Society for Metabolic and Bariatric Surgery (ASMBS). This appointment marks a significant milestone for ASMBS, the foremost professional organization dedicated to addressing obesity through metabolic and bariatric surgery in the United States. Dr. Northup’s election underscores the evolving landscape of obesity treatment, where surgical interventions are increasingly integrated with emerging therapies.

Dr. Northup brings extensive leadership experience within ASMBS, having served as president-elect, vice-president, and chair of the Access to Care Committee. His efforts notably advanced insurance coverage initiatives, facilitating broader patient access to crucial surgical treatments for obesity and related metabolic disorders. This role complements his clinical expertise in metabolic and bariatric surgery, emphasizing the importance of policy impacts on healthcare delivery.

The president’s vision for ASMBS aligns with current shifts in obesity management brought on by new therapeutic classes such as GLP-1 receptor agonists. These medications, alongside revised payer policies and stronger validation of surgical safety and effectiveness, are redefining standards of care. Dr. Northup highlights the need for educating both patients and healthcare providers on the strategic positioning of surgery within a comprehensive, evidence-based obesity treatment continuum.

Metabolic and bariatric surgery remains the most effective intervention for severe obesity, offering durable weight loss and amelioration of comorbidities such as type 2 diabetes and cardiovascular disease. Despite these benefits and safety profiles comparable to routine procedures like gallbladder removal, only about 1% of eligible patients currently undergo surgery. With approximately 200,000 procedures performed in 2024, there is a vast potential for expanded utilization driven by improved access and education.

Board certified in general surgery with a specialized focus on metabolic and bariatric procedures, Dr. Northup also contributes to the academic advancement of the field as Associate Editor of the journal Surgery for Obesity and Related Diseases. His scholarly work includes clinical guidelines and editorial contributions to the upcoming third edition of The ASMBS Textbook of Metabolic and Bariatric Surgery.

ASMBS Chief Executive Officer Dr. Diane M. Enos lauded Dr. Northup as a proven leader poised to steer the organization through a transformative era in obesity care. His comprehensive approach bridges clinical innovation, advocacy, and education, reinforcing ASMBS’s mission to improve surgical outcomes and patient quality of life.

As obesity continues to pose significant health challenges globally, ASMBS under Dr. Northup’s stewardship aims to enhance multidisciplinary collaboration. This strategy ensures metabolic and bariatric surgery is recognized not as a standalone treatment but as an integral component of a broader therapeutic framework involving lifestyle modification, pharmacotherapy, and ongoing clinical management.

The election of Dr. Northup signals both a continuity of seasoned leadership and an adaptive response to the rapidly changing therapeutic environment, promising advancements that could reshape obesity care paradigms for millions of patients.

Subject of Research: Metabolic and bariatric surgery for obesity treatment
News Publication Date: July 9, 2026
Web References: https://asmbs.org/
Image Credits: ASMBS
Keywords: Metabolic disorders, bariatric surgery, obesity treatment, metabolic surgery, GLP-1 receptor agonists, surgical safety, healthcare policy, ASMBS

Tags: ASMBS president electionemerging obesity therapiesevolving standards in obesity treatmentGLP-1 receptor agonists in obesity managementhealthcare policy and insurance coverageMetabolic and bariatric surgery leadershipmultidisciplinary obesity careobesity treatment advancementspatient access to metabolic surgeryrole of surgery in comprehensive obesity managementsurgical interventions for obesitysurgical safety and effectiveness validation

Share12Tweet7Share2ShareShareShare1

Related Posts

First Clinical Trial of Stem Cell Therapy for Huntington’s Disease Announced

July 10, 2026

Plant Viruses Boost AI, Machine Learning, and Nanotech in Biotechnology

July 10, 2026

Stem Cell Therapy Shows One-Year Survival in Retinitis Pigmentosa Patients

July 10, 2026

Long-Term Stem Cell Data Boosts Chronic Stroke Recovery Research

July 10, 2026

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

First Clinical Trial of Stem Cell Therapy for Huntington’s Disease Announced

Plant Viruses Boost AI, Machine Learning, and Nanotech in Biotechnology

Stem Cell Therapy Shows One-Year Survival in Retinitis Pigmentosa Patients

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 84 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.